Contineum Therapeutics, Inc. Class A Common Stock CTNM
$8.56
-35.99%
at last close
Analyst Consensus
- Consensus Rating
- Buy (3 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $20.75
- Implied Upside
- +142.3%
- Price Target Range
- $17.00 – $24.00
- Analysts (12 mo)
- 4
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-28 | Morgan StanleyJeffrey Hung |
Maintains | Equal-weight | $18 → $17 |
| 2026-09-15 | Jones TradingDebanjana Chatterjee |
Maintains | Buy | $26 → $24 |
| 2026-09-15 | BairdJoel Beatty |
Maintains | Outperform | $20 → $19 |
| 2026-07-31 | RBC CapitalBrian Abrahams |
Maintains | Outperform | $22 → $23 |
| 2026-05-14 | Morgan StanleyJeffrey Hung |
Maintains | Equal-weight | $14 → $16 |
| 2026-03-06 | BairdJoel Beatty |
Maintains | Outperform | $14 → $20 |
| 2026-01-08 | Morgan StanleyJeffrey Hung |
Downgrades | Overweight → Equal-weight | $23 → $14 |
| 2025-11-24 | BairdJoel Beatty |
Maintains | Outperform | $16 → $14 |
| 2025-11-21 | RBC CapitalBrian Abrahams |
Maintains | Outperform | $25 → $22 |
| 2025-09-25 | Leerink PartnersFaisal Khurshid |
Initiates coverage on | Outperform | $20 |
| 2025-08-18 | Morgan StanleyJeffrey Hung |
Maintains | Overweight | $20 → $21 |
| 2025-05-19 | Morgan StanleyJeffrey Hung |
Maintains | Overweight | $25 → $20 |
| 2025-05-15 | RBC CapitalBrian Abrahams |
Reiterates | Outperform | $31 |
| 2025-03-13 | Jones TradingDebanjana Chatterjee |
Initiates coverage on | Buy | $23 |
| 2025-03-07 | Morgan StanleyJeffrey Hung |
Assumes | Overweight | $25 |
| 2025-03-07 | BairdJoel Beatty |
Maintains | Outperform | $32 → $16 |
| 2025-01-09 | RBC CapitalBrian Abrahams |
Reiterates | Outperform | $31 |
| 2024-11-07 | RBC CapitalBrian Abrahams |
Maintains | Outperform | $32 → $31 |
| 2024-10-22 | BairdJoel Beatty |
Initiates coverage on | Outperform | $32 |
| 2024-08-14 | RBC CapitalBrian Abrahams |
Maintains | Outperform | $30 → $32 |
| 2024-04-30 | RBC CapitalBrian Abrahams |
Initiates coverage on | Outperform | $30 |
| 2024-04-30 | StifelPaul Matteis |
Initiates coverage on | Buy | $29 |
| 2024-04-30 | Morgan StanleyJeffrey Hung |
Initiates coverage on | Overweight | $25 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $8.56
- Market Cap
- $503.37 million
- 52-Week Range
- $8.43 – $17.79
- Average Volume
- 916K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.